Moreover, it has been reported that this bioactive compound can reverse the epigenetic modifications resulting from DNA hypermethylation, via suppressing HDAC1 expression in both human breast cancer MCF7 and MDA-MB-231 cell lines. The gene discussed is HDAC1; the disease is breast carcinoma.